{"id":527274,"date":"2021-08-12T08:04:37","date_gmt":"2021-08-12T12:04:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/"},"modified":"2021-08-12T08:04:37","modified_gmt":"2021-08-12T12:04:37","slug":"acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/","title":{"rendered":"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021"},"content":{"rendered":"
\n

Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference.<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n STATEN ISLAND, N.Y.<\/span>
\n <\/span>, Aug. 12, 2021<\/span><\/span> \/PRNewswire\/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that David P. Luci<\/span>, President & CEO, will present at the Emerging Growth Conference as follows:<\/p>\n

\n\n\n\n\n
\n

\n Date:<\/span>\n <\/p>\n<\/td>\n

\n

\n Wednesday, August 18, 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Time:<\/span>\n <\/p>\n<\/td>\n

\n

\n 11:15 a.m. Eastern Time<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Webcast:\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n https:\/\/goto.webcasts.com\/starthere.jsp?ei=1486517&tp_key=3bd9735fe4&sti=acxp<\/a>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

This live, interactive online event will provide current stockholders and the investment community the opportunity to interact with David P. Luci<\/span>.\u00a0 As time permits, Mr. Luci may be able to respond to questions from participants.<\/p>\n

The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.acurxpharmaceuticals.com<\/a>, under the Investors section.<\/p>\n

\n About Acurx Pharmaceuticals, Inc.<\/b>\n <\/p>\n

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company’s approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D preclinical pipeline includes antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE) and Penicillin-Resistant Streptococcus pneumoniae (PRSP).\u00a0 \u00a0<\/p>\n

To learn more about Acurx Pharmaceuticals and its product pipeline, please visit www.acurxpharma.com<\/a>.\u00a0<\/p>\n

\n Investor Contact:
<\/b>Acurx Pharmaceuticals, Inc.
David P. Luci<\/span>, President & CEO
Tel:\u00a0 917-533-1469
Email:\u00a0 davidluci@acurxpharma.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021-301353864.html<\/a><\/p>\n

SOURCE Acurx Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. PR Newswire STATEN ISLAND, N.Y. , Aug. 12, 2021 \/PRNewswire\/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that David P. Luci, President & CEO, will present at the Emerging Growth Conference as follows: Date: Wednesday, August 18, 2021 Time: 11:15 a.m. Eastern Time Webcast:\u00a0 https:\/\/goto.webcasts.com\/starthere.jsp?ei=1486517&tp_key=3bd9735fe4&sti=acxp This live, interactive online event will provide current stockholders and the investment community the opportunity to interact with David P. Luci.\u00a0 As time permits, Mr. Luci may be able to respond to questions from … <\/p>\n

Continue reading “Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-527274","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAcurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. PR Newswire STATEN ISLAND, N.Y. , Aug. 12, 2021 \/PRNewswire\/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that David P. Luci, President & CEO, will present at the Emerging Growth Conference as follows: Date: Wednesday, August 18, 2021 Time: 11:15 a.m. Eastern Time Webcast:\u00a0 https:\/\/goto.webcasts.com\/starthere.jsp?ei=1486517&tp_key=3bd9735fe4&sti=acxp This live, interactive online event will provide current stockholders and the investment community the opportunity to interact with David P. Luci.\u00a0 As time permits, Mr. Luci may be able to respond to questions from … Continue reading "Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-12T12:04:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY72556&sd=2021-08-12\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021\",\"datePublished\":\"2021-08-12T12:04:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/\"},\"wordCount\":282,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY72556&sd=2021-08-12\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/\",\"name\":\"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY72556&sd=2021-08-12\",\"datePublished\":\"2021-08-12T12:04:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY72556&sd=2021-08-12\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY72556&sd=2021-08-12\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/","og_locale":"en_US","og_type":"article","og_title":"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021 - Market Newsdesk","og_description":"Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. PR Newswire STATEN ISLAND, N.Y. , Aug. 12, 2021 \/PRNewswire\/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that David P. Luci, President & CEO, will present at the Emerging Growth Conference as follows: Date: Wednesday, August 18, 2021 Time: 11:15 a.m. Eastern Time Webcast:\u00a0 https:\/\/goto.webcasts.com\/starthere.jsp?ei=1486517&tp_key=3bd9735fe4&sti=acxp This live, interactive online event will provide current stockholders and the investment community the opportunity to interact with David P. Luci.\u00a0 As time permits, Mr. Luci may be able to respond to questions from … Continue reading \"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-12T12:04:37+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY72556&sd=2021-08-12","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021","datePublished":"2021-08-12T12:04:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/"},"wordCount":282,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY72556&sd=2021-08-12","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/","name":"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY72556&sd=2021-08-12","datePublished":"2021-08-12T12:04:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY72556&sd=2021-08-12","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY72556&sd=2021-08-12"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acurx-pharmaceuticals-to-present-at-the-emerging-growth-conference-on-august-18-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Acurx Pharmaceuticals to Present at the Emerging Growth Conference on August 18, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/527274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=527274"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/527274\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=527274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=527274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=527274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}